Linked Data API

Show Search Form

Search Results

91630
registered interest false more like this
date less than 2014-09-11more like thismore than 2014-09-11
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hereditary Diseases remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, with reference to the Government response to the consultation on draft regulations to permit the use of new treatment techniques to prevent the transmission of a serious mitochondrial disease from mother to child, published in July 2014, whether his Department consulted (a) Dr Andy Greenfield, (b) Professor Peter Braude and (c) Professor Robin Lovell-Badge on the formulation of the statement on page 15 that (i) mitochondrial donation techniques do not alter personal characteristics and traits of the person and (ii) the proposed mitochondrial donation techniques do not constitute genetic modification. more like this
tabling member constituency Stoke-on-Trent South more like this
tabling member printed
Robert Flello more like this
uin 209135 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-13more like thismore than 2014-10-13
answer text <p>The Government’s position that mitochondrial donation techniques do not alter personal characteristics and traits of the person reflects information within the April 2011 scientific report of the Human Fertilisation and Embryology Authority convened Expert Panel. The Expert Panel membership at that time included Professor Peter Braude and Professor Robin Lovell-Badge.</p><p> </p><p> </p><p> </p><p>The working definition of genetic modification in humans, in relation to mitochondrial donation, was determined by the Department in consultation with the Chief Medical Officer for England.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-13T14:19:49.5212012Zmore like thisremove minimum value filter
answering member
4020
label Biography information for George Freeman more like this
tabling member
1569
label Biography information for Robert Flello more like this
177189
registered interest false more like this
date less than 2015-02-02more like thismore than 2015-02-02
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hereditary Diseases remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department has taken to help early diagnosis of very long-chain acyl-CoA dehydrogenase deficiency. more like this
tabling member constituency Harlow more like this
tabling member printed
Robert Halfon more like this
uin 222853 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-09more like thismore than 2015-02-09
answer text <p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation.</p><p> </p><p> </p><p> </p><p>The UK NSC is currently reviewing newborn screening for very long chain acyl CoA dehydrogenase deficiency (VLCADD) against its internationally recognised criteria. A public consultation on the screening review opened on 21 November 2014 and will close on 23 February 2015. A copy of the consultation is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.screening.nhs.uk/fattyacidoxidation" target="_blank">http://www.screening.nhs.uk/fattyacidoxidation</a></p><p> </p><p> </p><p> </p><p>Improving education and awareness of rare diseases across the healthcare professions, including VLCADD, is a commitment in the UK Strategy for Rare Diseases. The Department continues to work closely with its delivery partners to implement the Strategy.</p><p> </p> more like this
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
remove maximum value filtermore like thismore than 2015-02-09T15:58:41.897Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
3985
label Biography information for Robert Halfon more like this
171143
registered interest false more like this
date less than 2014-12-17more like thismore than 2014-12-17
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Hereditary Diseases remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps he is taking to raise awareness of very long chain acyl-CoA dehydrogenase deficiency among (a) practitioners and (b) the public. more like this
tabling member constituency Barnsley Central more like this
tabling member printed
Dan Jarvis more like this
uin 219149 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>Raising awareness of all rare diseases amongst practitioners and the public, including very long chain acyl-CoA dehydrogenase deficiency, is a commitment in the UK Strategy for Rare Diseases. The Department continues to work closely with NHS England to implement this commitment.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-01-05T16:21:42.08Zmore like thismore than 2015-01-05T16:21:42.08Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4243
label Biography information for Dan Jarvis more like this
99863
registered interest false more like this
date less than 2014-10-20more like thismore than 2014-10-20
answering body
Cabinet Office more like this
answering dept id 53 more like this
answering dept short name Cabinet Office more like this
answering dept sort name Cabinet Office more like this
hansard heading Hereditary Diseases remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Minister for the Cabinet Office, how many infant deaths were caused by MCAD deficiency in (a) East Lancashire, (b) the North West and (c) England in each of the last three years. more like this
tabling member constituency Pendle more like this
tabling member printed
Andrew Stephenson more like this
uin 211015 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-23more like thismore than 2014-10-23
answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p><p> </p> more like this
answering member constituency Reading East more like this
answering member printed Mr Rob Wilson more like this
question first answered
less than 2014-10-23T15:48:38.3349681Zmore like thismore than 2014-10-23T15:48:38.3349681Z
answering member
1556
label Biography information for Mr Rob Wilson more like this
attachment
1
file name PQ 211015 ONS 359.pdf more like this
title ONS Letter to Member - Infant Deaths more like this
tabling member
4044
label Biography information for Andrew Stephenson more like this